4.7 Article

Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington's disease by etanercept treatment

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease mice

Marie K. Bondulich et al.

SCIENTIFIC REPORTS (2017)

Article Biochemistry & Molecular Biology

Rapid mitochondrial dysfunction mediates TNF-alpha-induced neurotoxicity

Danielle N. Doll et al.

JOURNAL OF NEUROCHEMISTRY (2015)

Article Medicine, General & Internal

Huntington disease

Gillian P. Bates et al.

NATURE REVIEWS DISEASE PRIMERS (2015)

Article Biochemistry & Molecular Biology

Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease

Han-Yun Hsiao et al.

HUMAN MOLECULAR GENETICS (2014)

Article Biochemistry & Molecular Biology

IL-1 and TNF- induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase

Ling Ye et al.

JOURNAL OF NEUROCHEMISTRY (2013)

Review Cell Biology

NF-κB, the first quarter-century: remarkable progress and outstanding questions

Matthew S. Hayden et al.

GENES & DEVELOPMENT (2012)

Review Pharmacology & Pharmacy

Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors

Devesh Mewar et al.

BRITISH JOURNAL OF PHARMACOLOGY (2011)

Article Neurosciences

Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases

Kathryn A. Frankola et al.

CNS & Neurological Disorders-Drug Targets (2011)

Article Pharmacology & Pharmacy

Neuroprotection with a Brain-Penetrating Biologic Tumor Necrosis Factor Inhibitor

Qing-Hui Zhou et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)

Article Biochemistry & Molecular Biology

Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease

Kirupa Sathasivam et al.

HUMAN MOLECULAR GENETICS (2010)

Article Neurosciences

Distinct neuroinflammatory profile in post-mortem human Huntington's disease

Aurelio Silvestroni et al.

NEUROREPORT (2009)

Article Immunology

A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease

Maria Bjorkqvist et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2008)

Article Biochemistry & Molecular Biology

Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release

Peter Thornton et al.

JOURNAL OF NEUROCHEMISTRY (2006)

Article Multidisciplinary Sciences

Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons

K Del Villar et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Medicine, General & Internal

Infliximab maintenance therapy for fistulizing Crohn's disease

BE Sands et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Immunology

Interleukin-6 produces neuronal loss in developing cerebellar granule neuron cultures

SM Conroy et al.

JOURNAL OF NEUROIMMUNOLOGY (2004)

Review Immunology

Signalling pathways of the TNF superfamily: A double-edged sword

BB Aggarwal

NATURE REVIEWS IMMUNOLOGY (2003)

Article Neurosciences

Local neuroinflammation and the progression of Alzheimer's disease

PL McGeer et al.

JOURNAL OF NEUROVIROLOGY (2002)

Article Clinical Neurology

Environmental enrichment slows disease progression in R61/2 Huntington's disease mice

E Hockly et al.

ANNALS OF NEUROLOGY (2002)

Review Biochemistry & Molecular Biology

The TNF and TNF receptor superfamilies: Integrating mammalian biology

RM Locksley et al.